Provided by Tiger Fintech (Singapore) Pte. Ltd.

Universe Pharmaceuticals Inc.

0.1030
-0.0178-14.74%
Post-market: 0.1024-0.0006-0.60%19:59 EDT
Volume:2.59M
Turnover:257.89K
Market Cap:1.57M
PE:0.00
High:0.1101
Open:0.1050
Low:0.0911
Close:0.1208
Loading ...

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

GlobeNewswire
·
03 Mar

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

Business Wire
·
03 Mar

Laureate Education, Inc. (LAUR): Among the Best Education Stocks to Buy in 2025

Insider Monkey
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-MercadoLibre, CrowdStrike Holdings, Protagonist Therapeutics

Reuters
·
22 Feb

Gold Moves Higher; Estée Lauder Shares Slide

Benzinga
·
05 Feb

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Benzinga
·
04 Feb

BRIEF-Universe Pharmaceuticals Inc Receives Nasdaq Delisting Notice Subject To Hearing Request

Reuters
·
04 Feb

Universe Pharmaceuticals gets Nasdaq delisting notice

TIPRANKS
·
04 Feb

Universe Pharmaceuticals Inc Receives Nasdaq Delisting Notice Subject to Hearing Request

THOMSON REUTERS
·
04 Feb

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

GlobeNewswire
·
04 Feb

Universe Pharmaceuticals Announces Extraordinary General Meeting for Share Consolidation

TIPRANKS
·
30 Jan

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

PR Newswire
·
14 Jan

Universe Pharmaceuticals Files Registration for 37.5 Million Shares

TIPRANKS
·
13 Dec 2024

BRIEF-Univest Securities Announces Closing Of $15 Million Registered Direct Offering

Reuters
·
11 Dec 2024

Univest Securities, Llc Announces Closing of $15 Million Registered Direct Offering for Its Client Universe Pharmaceuticals Inc (Nasdaq: Upc)

THOMSON REUTERS
·
11 Dec 2024

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

GlobeNewswire
·
11 Dec 2024